Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -10.36M
June 30, 2026 -8.165M
March 31, 2026 -11.64M
December 31, 2025 -6.797M
September 30, 2025 -11.09M
June 30, 2025 -8.95M
March 31, 2025 -10.12M
December 31, 2024 -8.744M
September 30, 2024 -7.274M
June 30, 2024 -8.928M
March 31, 2024 -12.12M
December 31, 2023 -9.896M
September 30, 2023 -5.184M
June 30, 2023 -9.475M
Date Value
March 31, 2023 -8.139M
December 31, 2022 -7.276M
September 30, 2022 -5.386M
June 30, 2022 6.136M
March 31, 2022 -15.65M
December 31, 2021 -14.36M
September 30, 2021 -15.20M
June 30, 2021 -10.53M
March 31, 2021 -12.55M
December 31, 2020 20.59M
September 30, 2020 -21.94M
June 30, 2020 -12.80M
March 31, 2020 -8.733M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Lineage Cell Therapeutics, Inc. -5.62M
Armata Pharmaceuticals, Inc. -5.516M
Voyager Therapeutics, Inc. -19.67M
Black Diamond Therapeutics, Inc. -8.338M
Invivyd, Inc. -32.11M